We are live on ! Find out more
BG

Bahl & Gaynor Portfolio holdings

AUM $19.8B
1-Year Est. Return 19.53%
This Fund
S&P 500
This Quarter Est. Return
+12.83%
1 Year Est. Return
+19.53%
3 Year Est. Return
+63.97%
5 Year Est. Return
+84.2%
10 Year Est. Return
+296.44%
AUM
$10.9B
AUM Growth
+$1.55B
Cap. Flow
+$431M
Cap. Flow %
3.95%
Top 10 Hldgs %
31.03%
Holding
358
New
19
Increased
175
Reduced
113
Closed
11

Top Buys

Rank Stock Value
1
CVX icon
Chevron
CVX
+$69.5M
2
CMCSA icon
Comcast
CMCSA
+$57.3M
3
ADP icon
Automatic Data Processing
ADP
+$50.3M
4
SPG icon
Simon Property Group
SPG
+$47.8M
5
KO icon
Coca-Cola
KO
+$42.8M

Top Sells

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$99.3M
2
AMGN icon
Amgen
AMGN
+$63.5M
3
MKC icon
McCormick & Company Non-Voting
MKC
+$44.1M
4
MO icon
Altria Group
MO
+$37.2M
5
ABT icon
Abbott
ABT
+$24.9M

Sector Composition

Rank Sector Weight
1 Technology 20.61%
2 Healthcare 14.46%
3 Financials 13.86%
4 Industrials 10.4%
5 Consumer Staples 8.58%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MSFT icon
1
Microsoft
MSFT
$2.93T
$505M 4.63%
4,280,165
+8,923
+0.2% +$974K
CSCO icon
2
Cisco
CSCO
$441B
$414M 3.8%
7,676,866
+420,546
+6% +$20.4M
NEE icon
3
NextEra Energy
NEE
$185B
$384M 3.52%
7,937,808
+232,612
+3% +$10.6M
JPM icon
4
JPMorgan Chase
JPM
$907B
$359M 3.29%
3,548,264
+143,147
+4% +$14.7M
HD icon
5
Home Depot
HD
$338B
$329M 3.02%
1,716,604
+74,412
+5% +$13.6M
TXN icon
6
Texas Instruments
TXN
$258B
$312M 2.86%
2,937,065
+143,032
+5% +$14.8M
JNJ icon
7
Johnson & Johnson
JNJ
$609B
$280M 2.57%
2,002,234
+23,861
+1% +$3.2M
HON icon
8
Honeywell
HON
$71.3B
$272M 2.5%
1,816,515
+73,695
+4% +$10.3M
TFC icon
9
Truist Financial
TFC
$65.4B
$267M 2.45%
5,746,137
+184,617
+3% +$9.01M
PEP icon
10
PepsiCo
PEP
$187B
$261M 2.4%
2,131,256
+51,560
+2% +$5.88M
MCD icon
11
McDonald's
MCD
$190B
$258M 2.36%
1,357,814
+98,044
+8% +$17.8M
APD icon
12
Air Products & Chemicals
APD
$65.8B
$251M 2.3%
1,313,060
+38,911
+3% +$6.7M
ABT icon
13
Abbott
ABT
$175B
$236M 2.17%
2,953,709
-334,671
-10% -$24.9M
PG icon
14
Procter & Gamble
PG
$349B
$224M 2.06%
2,154,238
-28,367
-1% -$2.76M
LMT icon
15
Lockheed Martin
LMT
$117B
$213M 1.96%
710,413
+47,413
+7% +$13.9M
CVX icon
16
Chevron
CVX
$373B
$209M 1.92%
1,697,462
+587,087
+53% +$69.5M
SBUX icon
17
Starbucks
SBUX
$120B
$204M 1.87%
2,741,030
+102,382
+4% +$7.04M
CCI icon
18
Crown Castle
CCI
$34.6B
$203M 1.86%
1,588,102
+65,707
+4% +$7.71M
MMM icon
19
3M
MMM
$83.4B
$203M 1.86%
1,165,998
+21,682
+2% +$3.65M
PAYX icon
20
Paychex
PAYX
$40.7B
$199M 1.82%
2,481,193
+90,075
+4% +$6.64M
AMGN icon
21
Amgen
AMGN
$198B
$191M 1.75%
1,003,760
-332,295
-25% -$63.5M
MRSH
22
Marsh
MRSH
$87.8B
$185M 1.7%
1,972,109
+39,677
+2% +$3.51M
MDT icon
23
Medtronic
MDT
$106B
$180M 1.65%
1,975,798
+38,305
+2% +$3.43M
SRE icon
24
Sempra
SRE
$60.3B
$166M 1.53%
2,642,450
+238,740
+10% +$14.1M
ITW icon
25
Illinois Tool Works
ITW
$79.4B
$163M 1.49%
1,133,815
+17,934
+2% +$2.48M

Similar funds

Bahl & Gaynor's Q1 2019 Portfolio in Review

As of Q1 2019, Bahl & Gaynor held 358 positions worth $10.9B, up 17% from $9.35B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Bahl & Gaynor deployed $431M of net new capital in Q1 2019, opening 19 new positions and adding to 175 existing holdings. Its largest new stake was Eaton: 47,492 shares worth $3.83M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 19% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was AbbVie, an estimated $99.3M trimmed.

  • Bahl & Gaynor's largest Q1 2019 buy was Eaton: 47,492 shares worth $3.83M.
  • Bahl & Gaynor added most to Chevron in Q1 2019, an estimated $69.5M increase.
  • Bahl & Gaynor's biggest Q1 2019 reduction was AbbVie, cutting an estimated $99.3M.
  • Bahl & Gaynor fully exited Whirlpool in Q1 2019, selling an estimated $2.03M.
  • Bahl & Gaynor's ten largest holdings make up 31% of its $10.9B portfolio in Q1 2019.
  • Bahl & Gaynor opened 19 new positions and closed 11 in Q1 2019.
  • Bahl & Gaynor's portfolio value rose 17% quarter-over-quarter to $10.9B.

Based on Bahl & Gaynor's 13F filing for Q1 2019, filed 13 May 2019.